We are live on ! Find out more
Delek Group

Delek Group Portfolio holdings

AUM $2.59B Turnover 32.94%
1-Year Est. Return 1.24%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.59B
AUM Growth
+$180M
Cap. Flow
-$12M
Cap. Flow %
-0.46%
Top 10 Hldgs %
27.3%
Holding
255
New
49
Increased
70
Reduced
72
Closed
35
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.9 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.6 years
Top 20 Avg Time Held Equity only
0.9 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 26%
2 Technology 14.15%
3 Healthcare 11.72%
4 Industrials 9.3%
5 Materials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
B icon
51
Barrick Mining
B
$66.7B
$20M 0.77%
+1,300,000
New +$17.3M
2019 Q2
0 quarters
PRGO icon
52
Perrigo
PRGO
$2.26B
$19.8M 0.77%
429,120
+16,441
+4% +$783K
2017 Q4
6 quarters
SPY icon
53
State Street SPDR S&P 500 ETF Trust
SPY
$820B
$19.8M 0.77%
68,955
-21,459
-24% -$6.18M
2017 Q4
6 quarters
ITRN icon
54
Ituran Location and Control
ITRN
$992M
$19.4M 0.75%
653,437
+181,501
+38% +$6.12M
2017 Q4
6 quarters
SYY icon
55
Sysco
SYY
$40.3B
$19.3M 0.75%
+280,000
New +$19.9M
2019 Q2
0 quarters
TEVA icon
56
CALL
Teva Pharmaceutical Industries Limited
TEVA
$48.3B
$19M 0.73%
+2,057,900
New +$24.8M
2019 Q2
0 quarters
AGN
57
DELISTED
Allergan plc
AGN
$18.3M 0.71%
112,159
-19,865
-15% -$2.75M
2019 Q1
1 quarter
STZ icon
58
Constellation Brands
STZ
$22.4B
$17.7M 0.68%
92,000
-30,000
-25% -$5.86M
2018 Q4
2 quarters
CAG icon
59
Conagra Brands
CAG
$6.84B
$17.3M 0.67%
667,098
+100,000
+18% +$2.9M
2017 Q4
6 quarters
GM icon
60
General Motors
GM
$68.6B
$16.9M 0.65%
448,613
-391
-0.1% -$14.7K
2017 Q4
6 quarters
GILD icon
61
Gilead Sciences
GILD
$192B
$16.6M 0.64%
250,400
-35,636
-12% -$2.34M
2017 Q4
6 quarters
KSS icon
62
Kohl's
KSS
$2.4B
$15.9M 0.62%
342,780
+120,000
+54% +$7.24M
2019 Q1
1 quarter
ESLT icon
63
Elbit Systems
ESLT
$35.3B
$15.6M 0.6%
106,961
+6,914
+7% +$991K
2017 Q4
6 quarters
GILT icon
64
Gilat Satellite Networks
GILT
$607M
$15.2M 0.59%
1,840,308
-56,210
-3% -$482K
2017 Q4
6 quarters
MRK icon
65
Merck
MRK
$366B
$15.1M 0.58%
191,844
-36,680
-16% -$2.81M
2017 Q4
6 quarters
HAS icon
66
Hasbro
HAS
$14.5B
$14.7M 0.57%
141,951
-20,000
-12% -$1.97M
2018 Q3
3 quarters
URGN icon
67
UroGen Pharma
URGN
$1.71B
$14.3M 0.55%
408,303
+95,192
+30% +$3.51M
2018 Q3
3 quarters
SLGL icon
68
Sol-Gel Technologies
SLGL
$213M
$13.8M 0.53%
154,550
+7,659
+5% +$611K
2018 Q1
5 quarters
IVV icon
69
iShares Core S&P 500 ETF
IVV
$887B
$13.7M 0.53%
47,664
– –
2017 Q4
6 quarters
ICL icon
70
ICL Group
ICL
$6.35B
$13.7M 0.53%
2,681,491
-931,832
-26% -$4.93M
2017 Q4
6 quarters
AGT
71
DELISTED
iShares MSCI Argentina and Global Exposure ETF
AGT
$13.5M 0.52%
497,870
– –
2017 Q4
6 quarters
VRNT icon
72
DELISTED
Verint Systems
VRNT
$13M 0.5%
496,723
-538,155
-52% -$16.2M
2017 Q4
6 quarters
VTRS icon
73
CALL
Viatris
VTRS
$21.1B
$12.9M 0.5%
678,100
+100,000
+17% +$2.21M
2017 Q4
6 quarters
VOO icon
74
Vanguard S&P 500 ETF
VOO
$1.04T
$12.7M 0.49%
48,225
– –
2017 Q4
6 quarters
FOLD icon
75
DELISTED
Amicus Therapeutics
FOLD
$12.4M 0.48%
1,021,096
+175,000
+21% +$2.22M
2017 Q4
6 quarters

Similar funds

Delek Group's Q2 2019 Portfolio in Review

As of Q2 2019, Delek Group held 255 positions worth $2.59B, up 7.5% from $2.41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Delek Group's Q2 2019 filing shows 49 new, 70 increased, 72 reduced and 35 closed positions. Its largest new stake was Philip Morris: 340,000 shares worth $26.4M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $50.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

  • Delek Group's largest Q2 2019 buy was Philip Morris: 340,000 shares worth $26.4M.
  • Delek Group added most to iShares US Healthcare Providers ETF in Q2 2019, an estimated $28.1M increase.
  • Delek Group's biggest Q2 2019 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $50.7M.
  • Delek Group fully exited Southern Copper in Q2 2019, selling an estimated $19.3M.
  • Delek Group's ten largest holdings make up 27% of its $2.59B portfolio in Q2 2019.
  • Delek Group opened 49 new positions and closed 35 in Q2 2019.
  • Delek Group's portfolio value rose 7.5% quarter-over-quarter to $2.59B.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.